{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:25:41Z","timestamp":1787761541692,"version":"build-2784847793"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309799\/2017-1"],"award-info":[{"award-number":["309799\/2017-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cca.2020.05.034","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:54:47Z","timestamp":1589630087000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Uric acid and kidney damage in systemic lupus erythematosus"],"prefix":"10.1016","volume":"508","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-1317","authenticated-orcid":false,"given":"Mariane","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Ver\u00edssimo","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Noal","family":"Moresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.05.034_b0005","unstructured":"M. Di Battista, E. Marcucci, E. Elefante, A. Tripoli, G. Governato, D. Zucchi, C. Tani, A. Alunno, E. Marcucci, E. Elefante, A. Tripoli, D. Zucchi, Review One year in review 2018: systemic lupus erythematosus, 2018, pp. 763\u2013777."},{"key":"10.1016\/j.cca.2020.05.034_b0010","doi-asserted-by":"crossref","unstructured":"S. Silpa-archa, J.J. Lee, C.S. Foster, Ocular manifestations in systemic lupus erythematosus, 2016, 135\u2013141. doi: 10.1136\/bjophthalmol-2015-306629.","DOI":"10.1136\/bjophthalmol-2015-306629"},{"key":"10.1016\/j.cca.2020.05.034_b0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5152\/eurjrheum.2017.160086","article-title":"Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients","volume":"4","author":"Teke","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000\u20132004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2020.05.034_b0025","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00296-009-1151-9","article-title":"Male gender results in more severe lupus nephritis","volume":"30","author":"de Carvalho","year":"2010","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cca.2020.05.034_b0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Liu","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2020.05.034_b0035","first-page":"1","article-title":"Lupus nephritis: an overview of recent findings","author":"de Zubiria Salgado","year":"2012","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2020.05.034_b0045","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10067-018-3991-8","article-title":"Serum uric acid levels are associated with lupus nephritis in patients with normal renal function","volume":"37","author":"Calich","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0050","doi-asserted-by":"crossref","unstructured":"A. Ribeiro-Oliveira, A.I. Nogueira, R.M. Pereira, W.W.V. Boas, R.A.S. Dos Santos, A.C. Sim\u00f5es e Silva, The renin-angiotensin system and diabetes: an update., Vasc. Health Risk Manage. 4 (2008) 787\u2013803. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19065996 (accessed September 9, 2019).","DOI":"10.2147\/VHRM.S1905"},{"key":"10.1016\/j.cca.2020.05.034_b0055","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10067-017-3538-4","article-title":"Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients","volume":"36","author":"Re\u00e1tegui-Sokolova","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0060","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-019-04620-3","article-title":"Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?","author":"Ugolini-Lopes","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0065","first-page":"2279","article-title":"Analysis of expression levels of IL-17 and IL-34 and influencing factors for prognosis in patients with lupus nephritis","volume":"17","author":"Cheng","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cca.2020.05.034_b0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/BOR.0000000000000480","article-title":"Epidemiology of systemic lupus erythematosus: an update","volume":"30","author":"Stojan","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0075","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2020.05.034_b0080","unstructured":"V. Tsioni, L. Andreoli, A. Meini, M. Frassi, E. Raffetti, P. Air\u00f2, F. Allegri, F. Donato, A. Tincani, The prevalence and incidence of systemic lupus erythematosus in children and adults: a population-based study in a mountain community in northern Italy., Clin. Exp. Rheumatol. 33 (n.d.) 681\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26089119 (accessed July 22, 2019)."},{"key":"10.1016\/j.cca.2020.05.034_b0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/annrheumdis-2014-206334","article-title":"The incidence and prevalence of systemic lupus erythematosus in the UK, 1999\u20132012","volume":"75","author":"Rees","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrrheum.2016.137","article-title":"The global burden of SLE: prevalence, health disparities and socioeconomic impact","volume":"12","author":"Carter","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10238-017-0479-9","article-title":"Systemic lupus erythematosus and ocular involvement: an overview","volume":"18","author":"Dammacco","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cca.2020.05.034_b0100","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.cca.2020.05.034_b0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells\u2019 contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2020.05.034_b0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.semarthrit.2016.10.005","article-title":"Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches","volume":"46","author":"dos Santos","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cca.2020.05.034_b0115","doi-asserted-by":"crossref","unstructured":"T.K. Nowling, G.S. Gilkeson, Mechanisms of tissue injury in lupus nephritis, Arthritis Res. Ther. 13 (2011) 250. doi: 10.1186\/ar3528.","DOI":"10.1186\/ar3528"},{"key":"10.1016\/j.cca.2020.05.034_b0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/096120300678828703","article-title":"Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus","volume":"9","author":"Wong","year":"2000","journal-title":"Lupus."},{"key":"10.1016\/j.cca.2020.05.034_b0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crisp\u00edn","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cca.2020.05.034_b0130","article-title":"Genetics of SLE: functional relevance for monocytes\/macrophages in disease","volume":"15","author":"Byrne","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cca.2020.05.034_b0135","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/ar1009","article-title":"B cell abnormalities in systemic lupus erythematosus","volume":"5","author":"Grammer","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2020.05.034_b0140","doi-asserted-by":"crossref","unstructured":"S. Karrar, D.S.C. Graham, Abnormal B Cell Development in Systemic Lupus Erythematosus What the Genetics Tell Us, (2017). doi:10.1002\/art.40396.","DOI":"10.1002\/art.40396"},{"key":"10.1016\/j.cca.2020.05.034_b0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar3251","article-title":"Abnormalities of T cell signaling in systemic lupus erythematosus","volume":"13","author":"Moulton","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2020.05.034_b0150","doi-asserted-by":"crossref","unstructured":"J.J. Weening, V.D. D\u2019Agati, M.M. Schwartz, S.V. Seshan, C.E. Alpers, G.B. Appel, J.E. Balow, J.A. Bruijn, T. Cook, F. Ferrario, A.B. Fogo, E.M. Ginzler, L. Hebert, G. Hill, P. Hill, J.C. Jennette, N.C. Kong, P. Lesavre, M. Lockshin, L.M. Looi, H. Makino, L.A. Moura, M. Nagata, I.S. of N.W.G. on the C. of L. Nephritis, R.P.S.W.G. on the C. of L. Nephritis, The classification of glomerulonephritis in systemic lupus erythematosus revisited, Kidney Int. 65 (2004) 521\u2013530. doi: 10.1111\/j.1523-1755.2004.00443.x.","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"key":"10.1016\/j.cca.2020.05.034_b0155","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"2019","key":"10.1016\/j.cca.2020.05.034_b0160","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0165","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.cca.2020.05.034_b0170","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/1744666X.2016.1206470","article-title":"Advances in the diagnosis and classification of systemic lupus erythematosus","volume":"12","author":"Larosa","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.cca.2020.05.034_b0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2020.05.034_b0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2006090992","article-title":"Collaborative study group, severe lupus nephritis: racial differences in presentation and outcome","volume":"18","author":"Korbet","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0185","first-page":"825","article-title":"Update on Lupus Nephritis","author":"Almaani","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0190","first-page":"73","article-title":"Large variability of the activity and chronicity indexes within and between histological classes of lupus nephritis","volume":"58","author":"Azoic\u0103i","year":"2017","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.cca.2020.05.034_b0195","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","article-title":"Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus","volume":"46","author":"Gergely","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2020.05.034_b0205","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2020.05.034_b0210","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox., Nucleosides","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleotides Nucleic Acids."},{"key":"10.1016\/j.cca.2020.05.034_b0215","article-title":"Uric acid induces renal inflammation via activating tubular NF-\u03baB signaling pathway","author":"Zhou","year":"2012","journal-title":"PLoS One. 7"},{"key":"10.1016\/j.cca.2020.05.034_b0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1051\/bmdcn\/2018080316","article-title":"Evaluation of serum uric acid level in systemic lupus erythematosus patients with normal and high pulmonary arterial hypertension","volume":"8","author":"Aghdashi","year":"2018","journal-title":"BioMedicine"},{"key":"10.1016\/j.cca.2020.05.034_b0225","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1756-185X.12262","article-title":"High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension","volume":"18","author":"Kim","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0230","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.rbr.2015.05.002","article-title":"Hyperuricemia in systemic lupus erythematosus: is it associated with the neuropsychiatric manifestations of the disease?","volume":"56","author":"Sheikh","year":"2016","journal-title":"Rev. Bras. Reumatol. (English Ed.)"},{"key":"10.1016\/j.cca.2020.05.034_b0235","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1177\/0961203311411348","article-title":"Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome","volume":"20","author":"Lozovoy","year":"2011","journal-title":"Lupus."},{"key":"10.1016\/j.cca.2020.05.034_b0240","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/rheumatology\/26.4.303","article-title":"Gout and hyperuricaemia in systemic lupus erythematosus","volume":"26","author":"Frocht","year":"1987","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.cca.2020.05.034_b0245","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00296-010-1373-x","article-title":"Association of serum uric acid with lupus nephritis in systemic lupus erythematosus","volume":"31","author":"Yang","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cca.2020.05.034_b0250","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000829","article-title":"Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis","volume":"94","author":"Mavragani","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2020.05.034_b0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrneph.2012.220","article-title":"Diagnosis and treatment of lupus nephritis flares\u2014an update","volume":"8","author":"Sprangers","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0260","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0272-6386(99)70082-X","article-title":"Clinical and prognostic value of serial renal biopsies in lupus nephritis","volume":"34","author":"Moroni","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0265","doi-asserted-by":"crossref","unstructured":"R. Saxena, T. Mahajan, C. Mohan, Lupus nephritis: current update, Arthritis Res. Ther. 13 (2011) 240. doi: 10.1186\/ar3378.","DOI":"10.1186\/ar3378"},{"key":"10.1016\/j.cca.2020.05.034_b0270","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0275","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology, American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.cca.2020.05.034_b0280","doi-asserted-by":"crossref","unstructured":"D.C. Cattran, J. Feehally, H.T. Cook, Z.H. Liu, F.C. Fervenza, S.A. Mezzano, J. Floege, P.H. Nachman, D.S. Gipson, M. Praga, R.J. Glassock, J. Radhakrishnan, E.M. Hodson, B.H. Rovin, V. Jha, S. Troyanov, P.K.T. Li, J.F.M. Wetzels, Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis, Kidney Int. Suppl. 2 (2012) 139\u2013274. doi:10.1038\/kisup.2012.9.","DOI":"10.1038\/kisup.2012.9"},{"key":"10.1016\/j.cca.2020.05.034_b0285","doi-asserted-by":"crossref","unstructured":"B.A. Pons-Estel, L.J. Catoggio, M.H. Cardiel, E.R. Soriano, S. Gentiletti, A.R. Villa, I. Abadi, F. Caeiro, A. Alvarellos, D. Alarc\u00f3n-Segovia, The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among \u201cHispanics\u201d., Medicine (Baltimore). 83 (2004) 1\u201317. doi:10.1097\/01.md.0000104742.42401.e2.","DOI":"10.1097\/01.md.0000104742.42401.e2"},{"key":"10.1016\/j.cca.2020.05.034_b0290","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/ard.2010.131482","article-title":"Patients of Hispanic Background Develop Lupus Nephritis (LN) Early in the Disease Course: Data from a Multiethnic US Cohort","volume":"70","author":"Burgos","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0295","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0300","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2020.05.034_b0305","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2020.05.034_b0310","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.ki.5002118","article-title":"The ISN\/RPS 2003 classification of lupus nephritis: an assessment at 3 years","volume":"71","author":"Markowitz","year":"2007","journal-title":"Kidney Int."},{"issue":"2019","key":"10.1016\/j.cca.2020.05.034_b0315","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0320","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","article-title":"Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2020.05.034_b0325","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","article-title":"Novel paradigms in systemic lupus erythematosus","volume":"393","author":"D\u00f6rner","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2020.05.034_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-017-0736-x","article-title":"Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation","volume":"18","author":"Romi","year":"2017","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0335","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/ATVBAHA.117.309128","article-title":"Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-\u03baB signaling pathway in HepG2 cells","volume":"37","author":"Spiga","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2020.05.034_b0340","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2020.05.034_b0345","first-page":"3435174","article-title":"Uric Acid Provides Protective Role in Red Blood Cells by Antioxidant Defense","volume":"2019","author":"Song","year":"2019","journal-title":"A Hypothetical Analysis., Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cca.2020.05.034_b0350","first-page":"2749","article-title":"Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases","volume":"10","author":"Wang","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cca.2020.05.034_b0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40620-018-0546-7","article-title":"The effect of polymorphism of uric acid transporters on uric acid transport","volume":"32","author":"Wang","year":"2019","journal-title":"J. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2014.04.080","article-title":"High uric acid directly inhibits insulin signalling and induces insulin resistance","volume":"447","author":"Zhu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2020.05.034_b0365","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.semnephrol.2011.08.012","article-title":"Uric acid and transplantation","volume":"31","author":"Mazali","year":"2011","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0370","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1055\/s-0042-113183","article-title":"Effect of antihypertensive drugs on uric acid metabolism in patients with hypertension: cross-sectional cohort study","volume":"66","author":"Ueno","year":"2016","journal-title":"Drug Res. (Stuttg)"},{"key":"10.1016\/j.cca.2020.05.034_b0375","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semnephrol.2004.09.007","article-title":"Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease","volume":"25","author":"Kanellis","year":"2005","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0380","first-page":"1","article-title":"The association of uric acid calculi with obesity, prediabetes, type 2 diabetes mellitus, and hypertension","volume":"2017","author":"Chu","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.cca.2020.05.034_b0385","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.amjhyper.2004.08.035","article-title":"A unifying pathway for essential hypertension","volume":"18","author":"Johnson","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2020.05.034_b0390","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000499939","article-title":"The role of uric acid in acute kidney injury","volume":"142","author":"Ejaz","year":"2019","journal-title":"Nephron."},{"key":"10.1016\/j.cca.2020.05.034_b0395","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2020.05.034_b0400","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2017.06.006","article-title":"Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice","volume":"74","author":"Aroor","year":"2017","journal-title":"Metabolism."},{"key":"10.1016\/j.cca.2020.05.034_b0405","doi-asserted-by":"crossref","first-page":"F993","DOI":"10.1152\/ajprenal.00637.2014","article-title":"Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy","volume":"308","author":"Kim","year":"2015","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.cca.2020.05.034_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.014","article-title":"Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation","volume":"103","author":"Guo","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2020.05.034_b0415","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/acs.jafc.7b05113","article-title":"Beneficial properties of phytochemicals on NLRP3 inflammasome-mediated gout and complication","volume":"66","author":"Jhang","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.cca.2020.05.034_b0420","first-page":"2611","article-title":"Involvement of TWEAK and the NF-\u03baB signaling pathway in lupus nephritis","volume":"15","author":"Sun","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cca.2020.05.034_b0425","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/0886022X.2018.1456463","article-title":"Effects of uric acid-lowering therapy on the progression of chronic kidney disease: A systematic review and meta-analysis","volume":"40","author":"Liu","year":"2018","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cca.2020.05.034_b0430","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s00296-011-1987-7","article-title":"Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus","volume":"32","author":"Yang","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cca.2020.05.034_b0435","first-page":"1052","article-title":"Hyperuricemia is an independent risk factor for renal pathological damage and poor prognosis in lupus nephritis patients","volume":"41","author":"Xie","year":"2016","journal-title":"Zhong Nan Da Xue Xue Bao. Yi Xue Ban."},{"key":"10.1016\/j.cca.2020.05.034_b0440","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/jcm9030773","article-title":"Serum Uric Acid is Associated with Renal Prognosis of Lupus Nephritis in Women but not in Men","volume":"9","author":"Oh","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2020.05.034_b0445","doi-asserted-by":"crossref","first-page":"57099","DOI":"10.18632\/oncotarget.19051","article-title":"The prevalence, subtypes and associated factors of hyperuricemia in lupus nephritis patients at chronic kidney disease stages 1\u20133","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.cca.2020.05.034_b0450","doi-asserted-by":"crossref","DOI":"10.1177\/2058739218802442","article-title":"Elevated uric acid levels in premenopausal female systemic lupus erythematosus patients: Association with potential or existing renal damage","volume":"16","author":"Liu","year":"2018","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.cca.2020.05.034_b0455","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0961203314555352","article-title":"Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus."},{"key":"10.1016\/j.cca.2020.05.034_b0460","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0961203319843343","article-title":"Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus."},{"key":"10.1016\/j.cca.2020.05.034_b0465","doi-asserted-by":"crossref","unstructured":"I.Y. Kim, D.W. Lee, S.B. Lee, I.S. Kwak, The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship., Biomed Res. Int. 2014 (2014) 638732. doi:10.1155\/2014\/638732.","DOI":"10.1155\/2014\/638732"},{"key":"10.1016\/j.cca.2020.05.034_b0470","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Ryu","year":"2013","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.cca.2020.05.034_b0475","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cca.2020.05.034_b0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-016-0433-1","article-title":"Hyperuricemia increases the risk of acute kidney injury: A systematic review and meta-analysis","volume":"18","author":"Xu","year":"2017","journal-title":"BMC Nephrol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120302382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120302382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:55:56Z","timestamp":1757861756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120302382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":96,"alternative-id":["S0009898120302382"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.05.034","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid and kidney damage in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}